glp-1 release Receptor Agonists Glucagon-like peptide 1 (GLP-1) -

That means your body is pumping out too much insulin, but instead of turning glucose into energy, it stores it as fat, especially around the belly (hello, PCOS belly)

This glucose-dependent action reduces the risk of dangerously low blood sugar (hypoglycemia), making them a safer option compared to some other diabetes treatments GLP-1 receptor agonists also reduce the likelihood of developing heart-related problems such as heart attacks or strokes

However, both injections increase the risk of gastrointestinal disorders, and the risk of tirzepatide is greater than that of liraglutide

The hormone's combined central and peripheral effects are attributable to its capacity to traverse the bloodbrain barrier, facilitating extensive metabolic control (Prete et al

Inflammation, metaflammation and immunometabolic disorders

However, this approach has not yet been adequately studied